Individualizing therapy in gastric cancer

References

• Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int.j Cancer80, 827–841 (1999).
   Google Scholar
• Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83, 2049–2053 (1998).
   Google Scholar
• agergren J, Bergstrom R, Lindgren A, Nyren 0. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl. J. Med. 340, 825–831 (1999).
   Google Scholar
• Siewert JR, Fink U, Sendler A etal Gastric cancer. Curt: Pm& Sing. 43, 837–937 (1997).
   Google Scholar
• Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Teat. Rev 26, 243–255 (2000).
   PubMedGoogle Scholar
• Siewert JR, Sendler A. The current management of gastric cancer. Adv Surg. 33, 69–93 (1999).
   PubMedGoogle Scholar
• Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br. Stay 85, 1457–1459 (1998).
   Google Scholar
• Ishigami S, Natsugoe S, Hokita S et al Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. j Clin Castroenterol 32, 41–44 (2001).
   PubMed Web of Science ®Google Scholar
• Rosch Th. Endosonographic staging of gastric cancer: a review of literature results. Castrointest. Clin. N. Am. 3, 549–557 (1995).
   Google Scholar
• ••Excellent overview of results and problemsin endosonography.
   Google Scholar
• Lightdale CJ. Endoscopic ultrasonography in the diagnosis, staging and follow-up of esophageal and gastric cancer. Endoscopy 24\(Suppl. 1), 297–303 (1992).
   Google Scholar
• Sohn KM, Lee JM, Lee SY et al. Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am. J Roentgenol 174,1551–1557 (2000) .
   PubMed Web of Science ®Google Scholar
• International Union Against Cancer. TNNI classification of malignant tumours; flh edition. Springer Verlag Berlin Heidelberg, NY, USA (2002).
   Google Scholar
• Sendler A, Dittler HJ, Feussner H et al. Preoperative staging of gastric cancer as precondition for multimodal treatment. Worldj Surg. 19, 501–508 (1995).
   PubMed Web of Science ®Google Scholar
• Weiss M, Eder M, Bassermann R. Charakterisierung verschiedener magenkarzinomtypen mit unterschiedlicher metastasierung in leber, peritoneum und knochen. Pathologe 14, 260–264 (1993).
   Google Scholar
• Fuchs CS, Mayer RJ. Gastric carcinoma. N. Engl. Med 333, 32–41 (1995).
   PubMed Web of Science ®Google Scholar
• Rode A, Bancel B, Douek P et al Small nodule detection in cirrhotic livers: evaluation with US, spiral CT and MRI and correlation with pathologic examination of explanted liver. J Comput. Assist. Tomogr 25, 327–336 (2001).
   PubMed Web of Science ®Google Scholar
• Feussner H, Omote K, Fink U, Walker SJ, Siewert JR. Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy31, 342–347 (1999).
   Google Scholar
• Lerut T, Flamen P, Ectors N et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann. Stay 232, 743–752 (2000).
   Google Scholar
• Kole AC, Plukker JT, Nieweg OE, Vaalburg W Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. BE J Cancer 78, 521–527 (1998).
   Google Scholar
• Yoshioka T, Yamaguchi K, Kubota K et al Evaluation of (18)F-FDG PET in patients with advanced, metastatic or recurrent gastric cancer. J Nucl. Med. 44, 690–699 (2003).
   Google Scholar
• Weber WA, Ott K, Becker K et al Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.j Clin. 0=119,3058-3065 (2001).
   Google Scholar
• Siewert JR, Böttcher K, Roder JD et al Prognostic relevance of systematic lymph node dissection: results of the German Gastric Carcinoma Study 1992. BE J Surg. 80,1015–1018 (1993).
   PubMed Web of Science ®Google Scholar
• Siewert JR, Kestlmeier R, Busch R et al Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. BE J Surg: 83,1144–1147 (1996).
   PubMedGoogle Scholar
• Ohgami M, Kumai K, Wakabayashi G, Otani Y, Katajima M. Innovative treatment for early gastric cancer: laparoscopic wedge resection of the stomach using the lesion-lifting method. Stomach Intestine 28, 1461–1468 (1993).
   Google Scholar
• Yanai H, Matsumoto Y, Harada T et al Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study. Gastrointest. Enclosc. 46,212–216 (1997).
   PubMed Web of Science ®Google Scholar
• Siewert JR, Böttcher K, Stein H, Roder JD and the German Gastric Carcinoma Study Group. Relevant prognostic factors in gastric cancer. Ann. Surg. 228,449–461 (1998).
   Google Scholar
• ••Final results of the German Gastric CancerStudy: one basis for extended lymphadenectomy.
   Google Scholar
• Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with nonresectable gastric cancer. BE J Cancer71, 587–591 (1995).
   Google Scholar
• Stein HJ, Sendler A, Siewert JR. Site- dependent resection techniques for gastric cancer. Surg. Oncol Gun. N Am. 11, 405–414 (2002).
   PubMedGoogle Scholar
• Japanese Gastric Cancer Association. Japanese classification of gastric cancer. Gastric Cancerl, 10–24 (1998).
   Google Scholar
• Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann. Surg. 210,596-602 (1989).
   Google Scholar
• Lee KY, Noh SH, Hyung WJ et al Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann. Surg: OncoI8, 402–406 (2001).
   PubMedGoogle Scholar
• Sano T, Kobori 0, Muto T Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. BE J Surg: 79,241–244 (1992).
   PubMedGoogle Scholar
• van de Velde CJH, Peeters KCMJ. The gastric cancer treatment controversy. j Gun. Oncol 21,2234 (2003).
   Google Scholar
• Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. BE J Cancer 79, 1522–1530 (1999).
   Google Scholar
• Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl. J. Med. 340, 908–914 (1999).
   Google Scholar
• Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer. Gastric Cancer 1, 152–159 (1998).
   Google Scholar
• Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery123, 573–578 (1998).
   Google Scholar
• Hartgrink HH, van de Velde CJ. Final results of the Dutch D1 versus D2 gastric cancer trial. Pmc. Int. Gastric Cancer Congress 68 (2003) (Abstract).
   Google Scholar
• Natsugoe S, Nakashima S, Matsumoto M et al Para-aortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma. Gastric Cancer 2,179–185 (1999).
   PubMedGoogle Scholar
• Brennan ME. Lymph node dissection for gastric cancer. N Engl J. Med. 340, 956–958 (1999).
   PubMedGoogle Scholar
• •Summarizes the controversy over D2 lymphadenectomy and comments on the problems of randomized studies in surgery.
   Google Scholar
• Estes NC, Macdonald JS, Touijer K, Benedetti J, Jacobson J. Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. Am. Surg. 64,680-685 (1998).
   Google Scholar
• ••Views on the problems of gastric cancersurgery in the USA and probably also in the Western world.
   Google Scholar
• White RE, Vezeridis MR Surgical palliation of gastric cancer. In: Surgery for Gastrointestinal Cancer Wanebo HJ (Ed.), Lippincott—Raven, Philadelphia, PA, USA, 355–361 (1997).
   Google Scholar
• Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E. Gastric cancer Springer—Verlag, Kanehara, Tokyo. 1–446 (1993).
   Google Scholar
• Roder JD, Böttcher K, Siewert JR et al Prognostic factors in gastric carcinoma. Cancer72, 2089–2097 (1993).
   PubMed Web of Science ®Google Scholar
• Wanebo HJ, Kennedy BJ, Chmiel J et al Cancer of the stomach. A patient care study by the American College of Surgeons. Ann. Surg: 218,583-592 (1993).
   Google Scholar
• Bollschweiler E, Böttcher K, Hölscher AH et al Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer71, 2918–2925 (1993).
   PubMed Web of Science ®Google Scholar
• Siewert JR, Sendler A. Potential and futility of sentinel node detection for gastric cancer. Recent Results Cancer Res. 157,259–269 (2000).
   PubMedGoogle Scholar
• Hiratsuka M, Miyashiro I, Ishikawa 0 et al Application of sentinel node biopsy to gastric cancer surgery. Surgery129, 335–340 (2001).
   PubMed Web of Science ®Google Scholar
• Kitagawa Y, Fujii H, Mukai M et al Radio- guided sentinel node detection for gastric cancer. Br. Surg. 89,604–608 (2002).
   PubMed Web of Science ®Google Scholar
• Kitagawa Y, Ohgami M, Fujii H et al Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann. Surg. OncoI8, 86S-89S (2001).
   Google Scholar
• Hermans J, Bonenkamp JJ, Boon MC et al Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Gun. Oncolll, 1441–1447 (1993).
   Google Scholar
• •Important meta-analysis demonstrating the problems in adjuvant treatment.
   Google Scholar
• Earle CC, Maronn JA. Adjuvant chemotherapy after curative resection for gastric cancer: revisiting a meta-analysis of randomized trials. Proc. Am. Soc. Gun. Oncoll7, 263a (1998) (Abstract).
   Google Scholar
• Mari E, Floriani I, Tinazzi A et al Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials, a study of the GISCAD (Gruppo Italian° per lo Studio dei Carcinomi dell'Apparato Digerente). Ann. Oncol11,837–843 (2000).
   PubMed Web of Science ®Google Scholar
• Panzini I, Gianni L, Fattori PP et al Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumor] 88,21–27 (2002).
   PubMed Web of Science ®Google Scholar
• ••Up-to-date meta-analysis whichdemonstrates some benefits for adjuvant chemotherapy.
   Google Scholar
• Nashimoto A, Nakajima T, Furukawa H et al Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206–1.1 Gun. Oncol 21,2282 (2003).
   Google Scholar
• ••
   Google Scholar
• Macdonald JS, Smalley SR, Benedetti J et al Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl. I Merl 345,725–730 (2001).
   PubMed Web of Science ®Google Scholar
• •Important trial on adjuvant therapy still under discussion.
   Google Scholar
• Hagiwara A, Takahashi T, Kojima 0 et al Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339,629–631 (1992).
   PubMed Web of Science ®Google Scholar
• FaB I, Zengel K, Reinicke T, Jansen M, Schumpelick V. Intraperitoneal therapy with carbon-absorbed mitomycin C in gastric cancer with serosal invasion. Cancer Res. Gun. Oncol 124, (1998).
   Google Scholar
• Vanhoefer U, Wilke H, Weh HJ et al. Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer. Ann. Oncol 5,850–851 (1994).
   Google Scholar
• Lowy AM, Mansfield PF, Leach SD et al Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann. Surg. 229,303–308 (1999).
   PubMed Web of Science ®Google Scholar
• ••First report on the benefits of neoadjuvant chemotherapy for responding patients.
   Google Scholar
• Ott K, Sendler A, Becker K et al Neoadjuvant chemotherapy with cisplatin, 5-FU and leucovorin (PLF) in locally advanced gastric cancer: a prospective Phase II study. Gastric Cancer (2003) (In press).
   Google Scholar
• Allum WH, Cunningham D, Weeden S. (For the UK NCRI Upper GI Clinical Studies Group). Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc. Am. Soc. Gun. Oncol 22, 998 (2003).
   Google Scholar
• Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Grit. Rev. Oncol Hematol 46, 59–100 (2003).
   PubMedGoogle Scholar
• •Excellent review.
   Google Scholar
• Weiss MM, Kuipers EJ, Postma C et al Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 22,1872–1879 (2003).
   PubMed Web of Science ®Google Scholar
• Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. BE Surg. 75,110-112 (1988).
   Google Scholar